May 2026 Recall: Clinical Approach to Monocular Vision Loss
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “May 2026 Recall: Clinical Approach to Monocular Vision Loss” inside PodZeus.
Monocular vision loss is not just a visual emergency—it's a neurovascular crisis requiring immediate, precise diagnosis and interdisciplinary collaboration. In this comprehensive Neurology® Podcast recall, neuro-ophthalmologists Nancy Newman and Valerie Buse from Emory University dismantle long-standing myths about central retinal artery occlusion (CRAO) and non-arteritic anterior ischemic optic neuropathy (NAION). They argue that CRAO is a true stroke of the retina, demanding the same urgency as cerebral infarction—'time is retina'—and that thrombolysis, though off-label, should be considered within 4.5 hours of vision loss, especially when imaging confirms the diagnosis. The episode exposes the dangerous gap between clinical intuition and diagnostic reality: most non-ophthalmologists cannot reliably diagnose CRAO with an ophthalmoscope, and point-of-care ultrasound is dangerously unreliable. Instead, the solution lies in deploying portable fundus cameras in emergency departments, enabling remote teleophthalmology and AI-assisted interpretation. For NAION, the podcast reveals a paradigm shift: it's not a simple 'stroke' but a compartment syndrome triggered by a congenitally crowded optic nerve head, with vascular risk factors and emerging drug associations—especially GLP-1 receptor agonists—now under intense scrutiny.
Diagnose CRAO with fundus photography or OCT—not an ophthalmoscope—because direct visualization is unreliable and delays care.
Time is retina: administer IV thrombolysis within 4.5 hours of vision loss if CRAO is confirmed by imaging, following stroke neurology protocols.
The risk of hemorrhage from IV thrombolysis in CRAO is low, and the benefit-risk threshold should be higher than for cerebral stroke due to vision's high personal value.
NAION is not a lacunar stroke; it's a compartment syndrome in a crowded optic nerve head, requiring evaluation of cup-to-disc ratio in the unaffected eye.
GLP-1 receptor agonists are associated with a modestly increased risk of NAION (likely <2x), but the absolute risk remains very low—do not screen all patients for optic nerve anatomy.
…and 3 more takeaways available in PodZeus
Introduction to the Neurology Recall Series
Jeff Ratliff introduces the May 2026 Neurology Recall, a curated compilation of two-part series on monocular vision loss. The episode features interviews with Emory University neuro-ophthalmologists Nancy Newman and Valerie Buse on central and branch retinal artery occlusions (CRAO/BRAO) and non-arteritic anterior ischemic optic neuropathy (NAION).
The Clinical Diagnosis of CRAO: Why 'Time is Retina'
“You need to have non-midgeriatric cameras in the emergency department that will allow the emergency department staff to take pictures themselves on every patient who presents with acute vision loss.”
Thrombolysis for CRAO: Off-Label but Logically Sound
“We went from 17 to 65. I love it. I'm giving thrombolysis to everyone. I know I am for sure. Yeah, me too. The problem? is that in the control group... visual recovery was between 45 and 48%.”
The Limits of Current Trials and the Hope for Meta-Analysis
“The truth is 65% versus 48%, I would still take it because they both showed that it was safe with one caveat.”
The Stroke Workup for CRAO: A Neurologist’s Responsibility
Nancy Newman and Valerie Buse challenge the outdated notion that carotid ultrasound is the first step. They assert that CRAO is a stroke and must be evaluated with a full stroke workup—ECG, cardiac monitoring for atrial fibrillation, and imaging—because the cause is often embolic, not carotid stenosis.
“we went from 17 to 65. I love it. I'm giving thrombolysis to everyone. I know I am for sure. Yeah, me too. The problem? is that in the control group, which was 300 milligram oral aspirin, the”
“need to have non -media cameras in the emergency department that will allow the emergency department staff to take pictures themselves on every patient who presents with acute vision loss.”
“The risk of NAON was greater than four times greater in the diabetes patients who were on semaglutide and was greater than seven times more frequent in those patients on semaglutide who were overweight or obese and taking it for that reason.”
Hosts
Guests
Nancy Newman
person
Valerie Buse
person
Emory University
organization
Dan Ackerman
person
Justin Abadamarco
person
Hathaway et al.
other
German revision trial
other
Kaiser Permanente
organization
Jeff Ratliff
person
Jose Merino
person
April 2026 Recall: Topics on Vascular Neurology
Neurology® Podcast • 1h 30m • 4/1/2026
Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD
Neurology® Podcast • 19m • 4/2/2026
Landmark Clinical Trials Shaping Patient Care
Neurology® Podcast • 12m • 4/6/2026
History of Letters to the Editor
Neurology® Podcast • 20m • 4/9/2026
2026 AAN President's Award Recipient - Dr. Walter J. Koroshetz
Neurology® Podcast • 26m • 4/16/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “May 2026 Recall: Clinical Approach to Monocular Vision Loss” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
